Anaptysbio (ANAB) Assets Average (2017 - 2026)

Anaptysbio has reported Assets Average for 10 years, with the latest figure at $347.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 23.38% year-over-year to $347.0 million; the trailing twelve-month figure through Mar 2026 stood at $347.0 million (down 23.38% YoY), and the FY2025 full-year result was $424.1 million, down 9.4% from the prior year.
• Assets Average for Q1 2026 stood at $347.0 million, down from $358.7 million in the prior quarter.
• The five-year high for Assets Average was $634.1 million in Q1 2022, with the low at $344.2 million in Q3 2025.
• Historically, Assets Average has averaged $484.6 million across 5 years, with a median of $469.9 million in 2023.
• Annual changes were most pronounced in 2022 — Assets Average jumped 56.0% — and 2025, when it declined 26.58%.
• Anaptysbio's Assets Average stood at $614.4 million in 2022, then slipped by 23.53% to $469.9 million in 2023, then climbed by 3.99% to $488.6 million in 2024, then decreased by 26.58% to $358.7 million in 2025, then slipped by 3.26% to $347.0 million in 2026.
• The last three Assets Average figures came in at $347.0 million (Q1 2026), $358.7 million (Q4 2025), and $344.2 million (Q3 2025), per Business Quant data.